Search Climate Insights Directory

The report examines the widespread use of glyphosate, noting a nearly 15-fold increase in global use since 1996 due to genetically modified crops. It details the emergence of glyphosate-resistant weeds and the contamination of surface and groundwater in Europe and North America. The document highlights scientific disputes over chronic toxicity, including carcinogenicity, and criticizes the Canadian Pest Management Regulatory Agency (PMRA) for its 2017 re-evaluation decision, which critics argue relied on outdated, non-peer-reviewed industry data.

A coalition of environmental and health organizations petitioned the FDA to remove prior sanctions for five ortho-phthalates and ban eight others, arguing that these substances are pharmacologically related and pose cumulative health risks. The petitioners assert that current dietary exposure for women and children exceeds a proposed safety tolerance of 3 μg/kg bw/day, particularly for DEHP, DINP, and DIDP. They argue that the FDA's existing approvals are based on outdated data and that the agency has failed to conduct necessary post-market evaluations since 2008.

The petition argues that the EPA's risk assessments for chlorpyrifos are flawed because they ignore robust peer-reviewed data on developmental neurotoxicity, endocrine disruption, and inhalation exposure. The petitioners claim that prenatal and early-life exposure causes permanent cognitive impairment and that the EPA's reliance on a 10% cholinesterase inhibition benchmark is insufficient to protect vulnerable populations. They further highlight that inhalation exposure in rural areas far exceeds dietary exposure and that the U.S. continues to export high volumes of the pesticide to developing countries.

The document challenges the PMRA's re-evaluation of glyphosate, claiming it relies heavily on outdated, confidential industry data while ignoring recent peer-reviewed literature and the exponential increase in glyphosate-based herbicide (GBH) use. It highlights significant gaps in the assessment of toxicological dangers, occupational risks, and food and water contamination, specifically citing concerns over carcinogenicity and endocrine disruption. The authors argue that the PMRA's findings contradict the precautionary spirit of the Pest Control Products Act and the Canadian Environmental Protection Act, calling for a suspension of the registration renewal and a transparent, independent re-evaluation of full herbicide formulations rather than just the active ingredient.

The document examines the risks associated with atrazine, a herbicide common in Canadian corn fields but banned in the European Union since 2003. It highlights the chemical's high leaching potential and frequent contamination of surface and groundwater, particularly in corn-growing regions of Québec. The briefing details atrazine's role as an endocrine disruptor, linking it to reproductive toxicity in animals—such as the feminization of frogs—and various reproductive health issues in humans, though it notes a lack of consensus on its carcinogenicity. It further discusses the synergistic toxicity of atrazine when mixed with other pesticides and critiques the Canadian Pest Management Regulatory Agency's (PMRA) limited scope in its risk reviews. Finally, it suggests that corn yields can be maintained through integrated pest management and mechanical weeding, supporting the call for a national ban.

The document examines the use and impact of atrazine in Canada and globally, highlighting its role as a significant environmental and health risk despite declining sales in Quebec. It details the chemical's persistence in surface and groundwater, its classification as an endocrine disruptor by several governments, and its toxic effects on wildlife, particularly amphibians. The text also discusses the lack of consensus on human carcinogenicity, the risks associated with pesticide 'cocktails', and the legal challenges surrounding its regulation in North America, ultimately advocating for a ban based on the European example.

The report details how decaBDE, used in plastics and textiles, acts as an endocrine disruptor and neurotoxin, disproportionately affecting children and workers. It frames these health risks as violations of international covenants, such as the ICCPR and CESCR, and calls for a global ban under the Stockholm Convention.

The report details how phthalates, used as plasticizers in a wide array of consumer and industrial products, act as endocrine disruptors and carcinogens. It highlights the vulnerability of children and fetuses, the risks to occupational workers, and the systemic failure to provide information or remedies to those exposed. The document links these health impacts to violations of international human rights frameworks, such as the ICCPR and CESCR, and notes that while some restrictions exist in the EU and US, DEHP remains widely used globally, particularly in the Global South.

The report details how phthalates, used as plasticizers in PVC and other products, act as endocrine disruptors linked to reproductive toxicity, cancer, and developmental issues. It argues that ubiquitous exposure through food, water, indoor air, and medical devices infringes upon human rights, particularly for vulnerable groups like children and workers, and highlights the lack of adequate product labeling and legal remedies for victims.

The document details the health hazards of HDQ Neutral, a quaternary ammonium compound (QAC) containing didecyldimethylammonium chloride (DDAC) and alkyl C-12-16 dimethyl benzyl ammonium chloride (ADBAC). Acute exposure can cause respiratory distress, skin blistering, and digestive burns, while short-term inhalation in animal studies suggests potential genotoxicity. Chronic exposure is linked to asthma in healthcare workers and severe reproductive issues in rodents, including infertility, low birth weight, and neural tube defects. The document concludes that these risks are concerning given the reported intensive use of the product at the ICE detention facility in Adelanto, California.